Capula Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Capula Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.84M	Sell	36,900 -24,500	-40%	-$3.31M	0.02%	172
2026 Q1	$7.84M	Buy	+61,400	New	+$7.66M	0.06%	95
2022 Q4	–	Sell	-123,400	Closed	-$9.79M	–	921
2022 Q3	$9.79M	Buy	123,400 +78,800	+177%	+$6.64M	0.13%	180
2022 Q2	$3.31M	Sell	44,600 -166,800	-79%	-$12.5M	0.06%	236
2022 Q1	$19M	Buy	+211,400	New	+$19.5M	0.27%	85

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Capula Management's XBI Position: Q2 2026 in Review

Capula Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 70% in Q2 2026, buying an estimated $2.45M and bringing the position to 44,038 shares worth $6.97M. The position accounts for 0.02% of the portfolio, ranked #159.

Capula Management first reported a position in XBI in Q3 2022 and has held it in 4 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Capula Management held 44,038 shares of State Street SPDR S&P Biotech ETF worth $6.97M as of Q2 2026.
Capula Management bought 18,105 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.45M.
State Street SPDR S&P Biotech ETF made up 0.02% of Capula Management's portfolio in Q2 2026, its #159 holding.
Capula Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 4 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.